These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16585504)
1. Determinants of specific RNA interference-mediated silencing of human beta-globin alleles differing by a single nucleotide polymorphism. Dykxhoorn DM; Schlehuber LD; London IM; Lieberman J Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5953-8. PubMed ID: 16585504 [TBL] [Abstract][Full Text] [Related]
2. Modification of globin gene expression by RNA targeting strategies. Shen TJ; Rogers H; Yu X; Lin F; Noguchi CT; Ho C Exp Hematol; 2007 Aug; 35(8):1209-18. PubMed ID: 17662889 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi. Ohnishi Y; Tamura Y; Yoshida M; Tokunaga K; Hohjoh H PLoS One; 2008 May; 3(5):e2248. PubMed ID: 18493311 [TBL] [Abstract][Full Text] [Related]
4. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference. Samakoglu S; Lisowski L; Budak-Alpdogan T; Usachenko Y; Acuto S; Di Marzo R; Maggio A; Zhu P; Tisdale JF; Rivière I; Sadelain M Nat Biotechnol; 2006 Jan; 24(1):89-94. PubMed ID: 16378095 [TBL] [Abstract][Full Text] [Related]
5. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of beta protein 1 expression enhances beta-globin promoter activity and beta-globin mRNA levels in the human erythroleukemia (K562) cell line. Zoueva OP; Rodgers GP Exp Hematol; 2004 Aug; 32(8):700-8. PubMed ID: 15308321 [TBL] [Abstract][Full Text] [Related]
7. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia. Alami R; Gilman JG; Feng YQ; Marmorato A; Rochlin I; Suzuka SM; Fabry ME; Nagel RL; Bouhassira EE Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593 [TBL] [Abstract][Full Text] [Related]
9. Site-specific base changes in the coding or promoter region of the human beta- and gamma-globin genes by single-stranded oligonucleotides. Yin W; Kren BT; Steer CJ Biochem J; 2005 Aug; 390(Pt 1):253-61. PubMed ID: 15828874 [TBL] [Abstract][Full Text] [Related]
10. Multi-ribozyme targeting of human alpha-globin gene expression. Shen TJ; Ikonomi P; Smith R; Noguchi CT; Ho C Blood Cells Mol Dis; 1999; 25(5-6):361-73. PubMed ID: 10660485 [TBL] [Abstract][Full Text] [Related]
12. Peptide nucleic acid (PNA) binding-mediated induction of human gamma-globin gene expression. Wang G; Xu X; Pace B; Dean DA; Glazer PM; Chan P; Goodman SR; Shokolenko I Nucleic Acids Res; 1999 Jul; 27(13):2806-13. PubMed ID: 10373600 [TBL] [Abstract][Full Text] [Related]
13. Microsatellite and single nucleotide polymorphisms in the β-globin locus control region-hypersensitive Site 2: SPECIFICITY of Tunisian βs chromosomes. Ben Mustapha M; Moumni I; Zorai A; Douzi K; Ghanem A; Abbes S Hemoglobin; 2012; 36(6):533-44. PubMed ID: 23101664 [TBL] [Abstract][Full Text] [Related]
14. Allele-specific silencing by RNA interference. Hohjoh H Methods Mol Biol; 2010; 623():67-79. PubMed ID: 20217544 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal β-like globin genes. Roosjen M; McColl B; Kao B; Gearing LJ; Blewitt ME; Vadolas J FASEB J; 2014 Apr; 28(4):1610-20. PubMed ID: 24371119 [TBL] [Abstract][Full Text] [Related]
16. Erythroid-specific expression of beta-globin by the sleeping beauty transposon for Sickle cell disease. Zhu J; Kren BT; Park CW; Bilgim R; Wong PY; Steer CJ Biochemistry; 2007 Jun; 46(23):6844-58. PubMed ID: 17508724 [TBL] [Abstract][Full Text] [Related]
17. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand. Yoo JW; Kim S; Lee DK Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261 [TBL] [Abstract][Full Text] [Related]
18. Designing siRNA that distinguish between genes that differ by a single nucleotide. Schwarz DS; Ding H; Kennington L; Moore JT; Schelter J; Burchard J; Linsley PS; Aronin N; Xu Z; Zamore PD PLoS Genet; 2006 Sep; 2(9):e140. PubMed ID: 16965178 [TBL] [Abstract][Full Text] [Related]
19. Nucleotide variation regulates the level of enhancement by hypersensitive site 2 of the beta-globin locus control region. Ofori-Acquah SF; Lalloz MR; Layton DM Blood Cells Mol Dis; 2001; 27(5):803-11. PubMed ID: 11783943 [TBL] [Abstract][Full Text] [Related]
20. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity. Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]